nodes	percent_of_prediction	percent_of_DWPC	metapath
Zileuton—UGT1A9—Irinotecan—lung cancer	0.142	0.249	CbGbCtD
Zileuton—PTGS1—Etoposide—lung cancer	0.0473	0.0829	CbGbCtD
Zileuton—CYP2C9—Gefitinib—lung cancer	0.0446	0.0781	CbGbCtD
Zileuton—CYP2C9—Teniposide—lung cancer	0.0432	0.0757	CbGbCtD
Zileuton—CYP1A2—Erlotinib—lung cancer	0.0292	0.0512	CbGbCtD
Zileuton—CYP3A4—Topotecan—lung cancer	0.0283	0.0496	CbGbCtD
Zileuton—CYP3A4—Gefitinib—lung cancer	0.0259	0.0454	CbGbCtD
Zileuton—CYP3A4—Teniposide—lung cancer	0.0251	0.044	CbGbCtD
Zileuton—CYP2C9—Paclitaxel—lung cancer	0.0241	0.0423	CbGbCtD
Zileuton—CYP1A2—Etoposide—lung cancer	0.0212	0.0371	CbGbCtD
Zileuton—CYP3A4—Vinorelbine—lung cancer	0.02	0.035	CbGbCtD
Zileuton—CYP2C9—Cisplatin—lung cancer	0.0194	0.034	CbGbCtD
Zileuton—CYP3A4—Crizotinib—lung cancer	0.0159	0.0278	CbGbCtD
Zileuton—CYP3A4—Erlotinib—lung cancer	0.0153	0.0268	CbGbCtD
Zileuton—CYP3A4—Paclitaxel—lung cancer	0.014	0.0246	CbGbCtD
Zileuton—CYP3A4—Irinotecan—lung cancer	0.0138	0.0242	CbGbCtD
Zileuton—CYP3A4—Vinblastine—lung cancer	0.0123	0.0215	CbGbCtD
Zileuton—CYP3A4—Etoposide—lung cancer	0.0111	0.0194	CbGbCtD
Zileuton—CYP3A4—Docetaxel—lung cancer	0.0101	0.0178	CbGbCtD
Zileuton—CYP3A4—Doxorubicin—lung cancer	0.00756	0.0132	CbGbCtD
Zileuton—EPHX2—mammary gland—lung cancer	0.00698	0.128	CbGeAlD
Zileuton—LTB4R—respiratory system—lung cancer	0.00632	0.116	CbGeAlD
Zileuton—LTB4R—bronchus—lung cancer	0.0052	0.0957	CbGeAlD
Zileuton—LTB4R—trachea—lung cancer	0.00467	0.0859	CbGeAlD
Zileuton—LTB4R—bone marrow—lung cancer	0.00371	0.0682	CbGeAlD
Zileuton—LTB4R—lung—lung cancer	0.00336	0.0617	CbGeAlD
Zileuton—ALOX5—respiratory system—lung cancer	0.00279	0.0513	CbGeAlD
Zileuton—EPHX2—lung—lung cancer	0.00247	0.0454	CbGeAlD
Zileuton—LTB4R—lymph node—lung cancer	0.0023	0.0422	CbGeAlD
Zileuton—ALOX5—bronchus—lung cancer	0.00229	0.0422	CbGeAlD
Zileuton—CYP2C9—mammary gland—lung cancer	0.00184	0.0338	CbGeAlD
Zileuton—EPHX2—lymph node—lung cancer	0.00169	0.0311	CbGeAlD
Zileuton—ALOX5—bone marrow—lung cancer	0.00163	0.03	CbGeAlD
Zileuton—ALOX5—lung—lung cancer	0.00148	0.0272	CbGeAlD
Zileuton—CYP1A2—respiratory system—lung cancer	0.00129	0.0237	CbGeAlD
Zileuton—PTGS1—respiratory system—lung cancer	0.00112	0.0206	CbGeAlD
Zileuton—ALOX5—lymph node—lung cancer	0.00101	0.0186	CbGeAlD
Zileuton—PTGS1—epithelium—lung cancer	0.000935	0.0172	CbGeAlD
Zileuton—PTGS1—trachea—lung cancer	0.000827	0.0152	CbGeAlD
Zileuton—PTGS1—cardiac atrium—lung cancer	0.000777	0.0143	CbGeAlD
Zileuton—CYP1A2—lung—lung cancer	0.000686	0.0126	CbGeAlD
Zileuton—PTGS1—lung—lung cancer	0.000594	0.0109	CbGeAlD
Zileuton—Pain—Topotecan—lung cancer	0.000485	0.00266	CcSEcCtD
Zileuton—Constipation—Topotecan—lung cancer	0.000485	0.00266	CcSEcCtD
Zileuton—Gastrointestinal disorder—Erlotinib—lung cancer	0.000485	0.00266	CcSEcCtD
Zileuton—Vaginal inflammation—Doxorubicin—lung cancer	0.000484	0.00265	CcSEcCtD
Zileuton—Flatulence—Irinotecan—lung cancer	0.000483	0.00265	CcSEcCtD
Zileuton—Rash—Teniposide—lung cancer	0.000483	0.00265	CcSEcCtD
Zileuton—Dermatitis—Teniposide—lung cancer	0.000482	0.00264	CcSEcCtD
Zileuton—Feeling abnormal—Vinblastine—lung cancer	0.000481	0.00264	CcSEcCtD
Zileuton—Sinusitis—Paclitaxel—lung cancer	0.00048	0.00263	CcSEcCtD
Zileuton—Pain—Erlotinib—lung cancer	0.00048	0.00263	CcSEcCtD
Zileuton—Constipation—Erlotinib—lung cancer	0.00048	0.00263	CcSEcCtD
Zileuton—Headache—Teniposide—lung cancer	0.00048	0.00263	CcSEcCtD
Zileuton—Lymphadenopathy—Methotrexate—lung cancer	0.000476	0.00261	CcSEcCtD
Zileuton—Feeling abnormal—Topotecan—lung cancer	0.000468	0.00256	CcSEcCtD
Zileuton—Vaginal infection—Doxorubicin—lung cancer	0.000457	0.0025	CcSEcCtD
Zileuton—Ill-defined disorder—Irinotecan—lung cancer	0.000455	0.00249	CcSEcCtD
Zileuton—Nausea—Teniposide—lung cancer	0.000455	0.00249	CcSEcCtD
Zileuton—Urticaria—Topotecan—lung cancer	0.000451	0.00247	CcSEcCtD
Zileuton—Body temperature increased—Topotecan—lung cancer	0.000449	0.00246	CcSEcCtD
Zileuton—Body temperature increased—Erlotinib—lung cancer	0.000444	0.00243	CcSEcCtD
Zileuton—Ill-defined disorder—Gemcitabine—lung cancer	0.000443	0.00243	CcSEcCtD
Zileuton—Malaise—Irinotecan—lung cancer	0.000442	0.00242	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Vinorelbine—lung cancer	0.000442	0.00242	CcSEcCtD
Zileuton—Flatulence—Cisplatin—lung cancer	0.000439	0.00241	CcSEcCtD
Zileuton—Malaise—Gemcitabine—lung cancer	0.000431	0.00236	CcSEcCtD
Zileuton—Hypersensitivity—Vinblastine—lung cancer	0.00043	0.00236	CcSEcCtD
Zileuton—Hypertonia—Doxorubicin—lung cancer	0.000424	0.00233	CcSEcCtD
Zileuton—Jaundice—Docetaxel—lung cancer	0.000423	0.00232	CcSEcCtD
Zileuton—Conjunctivitis—Docetaxel—lung cancer	0.000422	0.00231	CcSEcCtD
Zileuton—Gastrointestinal disorder—Vinorelbine—lung cancer	0.000419	0.0023	CcSEcCtD
Zileuton—Hypersensitivity—Topotecan—lung cancer	0.000418	0.00229	CcSEcCtD
Zileuton—Pain—Vinorelbine—lung cancer	0.000415	0.00227	CcSEcCtD
Zileuton—Constipation—Vinorelbine—lung cancer	0.000415	0.00227	CcSEcCtD
Zileuton—Ill-defined disorder—Cisplatin—lung cancer	0.000413	0.00226	CcSEcCtD
Zileuton—Discomfort—Irinotecan—lung cancer	0.000413	0.00226	CcSEcCtD
Zileuton—Lymphadenopathy—Doxorubicin—lung cancer	0.000412	0.00226	CcSEcCtD
Zileuton—Myalgia—Gemcitabine—lung cancer	0.000407	0.00223	CcSEcCtD
Zileuton—Chest pain—Gemcitabine—lung cancer	0.000407	0.00223	CcSEcCtD
Zileuton—Arthralgia—Gemcitabine—lung cancer	0.000407	0.00223	CcSEcCtD
Zileuton—PTGS1—lymph node—lung cancer	0.000406	0.00747	CbGeAlD
Zileuton—Discomfort—Gemcitabine—lung cancer	0.000402	0.0022	CcSEcCtD
Zileuton—Malaise—Cisplatin—lung cancer	0.000402	0.0022	CcSEcCtD
Zileuton—Pruritus—Topotecan—lung cancer	0.000401	0.0022	CcSEcCtD
Zileuton—Feeling abnormal—Vinorelbine—lung cancer	0.0004	0.00219	CcSEcCtD
Zileuton—Diarrhoea—Vinblastine—lung cancer	0.0004	0.00219	CcSEcCtD
Zileuton—Pruritus—Erlotinib—lung cancer	0.000397	0.00218	CcSEcCtD
Zileuton—Flatulence—Paclitaxel—lung cancer	0.000394	0.00216	CcSEcCtD
Zileuton—Tension—Paclitaxel—lung cancer	0.000393	0.00215	CcSEcCtD
Zileuton—Hepatitis—Docetaxel—lung cancer	0.000389	0.00213	CcSEcCtD
Zileuton—Nervousness—Paclitaxel—lung cancer	0.000389	0.00213	CcSEcCtD
Zileuton—Diarrhoea—Topotecan—lung cancer	0.000388	0.00213	CcSEcCtD
Zileuton—Dizziness—Vinblastine—lung cancer	0.000386	0.00212	CcSEcCtD
Zileuton—Urticaria—Vinorelbine—lung cancer	0.000386	0.00211	CcSEcCtD
Zileuton—Diarrhoea—Erlotinib—lung cancer	0.000384	0.00211	CcSEcCtD
Zileuton—Body temperature increased—Vinorelbine—lung cancer	0.000384	0.0021	CcSEcCtD
Zileuton—Myalgia—Cisplatin—lung cancer	0.000379	0.00208	CcSEcCtD
Zileuton—Ill-defined disorder—Etoposide—lung cancer	0.000379	0.00207	CcSEcCtD
Zileuton—Dizziness—Topotecan—lung cancer	0.000375	0.00206	CcSEcCtD
Zileuton—Discomfort—Cisplatin—lung cancer	0.000375	0.00205	CcSEcCtD
Zileuton—Vomiting—Vinblastine—lung cancer	0.000371	0.00204	CcSEcCtD
Zileuton—Dizziness—Erlotinib—lung cancer	0.000371	0.00203	CcSEcCtD
Zileuton—Ill-defined disorder—Paclitaxel—lung cancer	0.000371	0.00203	CcSEcCtD
Zileuton—Malaise—Etoposide—lung cancer	0.000368	0.00202	CcSEcCtD
Zileuton—Headache—Vinblastine—lung cancer	0.000366	0.00201	CcSEcCtD
Zileuton—Insomnia—Irinotecan—lung cancer	0.000362	0.00198	CcSEcCtD
Zileuton—Vomiting—Topotecan—lung cancer	0.000361	0.00198	CcSEcCtD
Zileuton—Malaise—Paclitaxel—lung cancer	0.000361	0.00198	CcSEcCtD
Zileuton—Rash—Topotecan—lung cancer	0.000358	0.00196	CcSEcCtD
Zileuton—Hypersensitivity—Vinorelbine—lung cancer	0.000358	0.00196	CcSEcCtD
Zileuton—Dermatitis—Topotecan—lung cancer	0.000357	0.00196	CcSEcCtD
Zileuton—Vomiting—Erlotinib—lung cancer	0.000357	0.00196	CcSEcCtD
Zileuton—Somnolence—Irinotecan—lung cancer	0.000356	0.00195	CcSEcCtD
Zileuton—Headache—Topotecan—lung cancer	0.000355	0.00195	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.000355	0.00195	CcSEcCtD
Zileuton—Rash—Erlotinib—lung cancer	0.000354	0.00194	CcSEcCtD
Zileuton—Dermatitis—Erlotinib—lung cancer	0.000354	0.00194	CcSEcCtD
Zileuton—Insomnia—Gemcitabine—lung cancer	0.000353	0.00193	CcSEcCtD
Zileuton—Dyspepsia—Irinotecan—lung cancer	0.000352	0.00193	CcSEcCtD
Zileuton—Headache—Erlotinib—lung cancer	0.000352	0.00193	CcSEcCtD
Zileuton—Chest pain—Etoposide—lung cancer	0.000347	0.0019	CcSEcCtD
Zileuton—Nausea—Vinblastine—lung cancer	0.000347	0.0019	CcSEcCtD
Zileuton—Somnolence—Gemcitabine—lung cancer	0.000347	0.0019	CcSEcCtD
Zileuton—Gastrointestinal disorder—Irinotecan—lung cancer	0.000346	0.00189	CcSEcCtD
Zileuton—Pruritus—Vinorelbine—lung cancer	0.000343	0.00188	CcSEcCtD
Zileuton—Discomfort—Etoposide—lung cancer	0.000343	0.00188	CcSEcCtD
Zileuton—Constipation—Irinotecan—lung cancer	0.000342	0.00188	CcSEcCtD
Zileuton—Pain—Irinotecan—lung cancer	0.000342	0.00188	CcSEcCtD
Zileuton—Chest pain—Paclitaxel—lung cancer	0.000341	0.00187	CcSEcCtD
Zileuton—Arthralgia—Paclitaxel—lung cancer	0.000341	0.00187	CcSEcCtD
Zileuton—Myalgia—Paclitaxel—lung cancer	0.000341	0.00187	CcSEcCtD
Zileuton—Nausea—Topotecan—lung cancer	0.000337	0.00185	CcSEcCtD
Zileuton—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000337	0.00185	CcSEcCtD
Zileuton—Discomfort—Paclitaxel—lung cancer	0.000336	0.00184	CcSEcCtD
Zileuton—Pain—Gemcitabine—lung cancer	0.000333	0.00183	CcSEcCtD
Zileuton—Constipation—Gemcitabine—lung cancer	0.000333	0.00183	CcSEcCtD
Zileuton—Nausea—Erlotinib—lung cancer	0.000333	0.00183	CcSEcCtD
Zileuton—Diarrhoea—Vinorelbine—lung cancer	0.000332	0.00182	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000331	0.00181	CcSEcCtD
Zileuton—Feeling abnormal—Irinotecan—lung cancer	0.00033	0.00181	CcSEcCtD
Zileuton—Upper respiratory tract infection—Methotrexate—lung cancer	0.000326	0.00179	CcSEcCtD
Zileuton—Feeling abnormal—Gemcitabine—lung cancer	0.000321	0.00176	CcSEcCtD
Zileuton—Dizziness—Vinorelbine—lung cancer	0.000321	0.00176	CcSEcCtD
Zileuton—Abdominal pain upper—Doxorubicin—lung cancer	0.000321	0.00176	CcSEcCtD
Zileuton—Body temperature increased—Irinotecan—lung cancer	0.000316	0.00173	CcSEcCtD
Zileuton—Gastrointestinal disorder—Cisplatin—lung cancer	0.000314	0.00172	CcSEcCtD
Zileuton—Pain—Cisplatin—lung cancer	0.000311	0.0017	CcSEcCtD
Zileuton—Vomiting—Vinorelbine—lung cancer	0.000309	0.00169	CcSEcCtD
Zileuton—Body temperature increased—Gemcitabine—lung cancer	0.000308	0.00169	CcSEcCtD
Zileuton—Rash—Vinorelbine—lung cancer	0.000306	0.00168	CcSEcCtD
Zileuton—Dermatitis—Vinorelbine—lung cancer	0.000306	0.00168	CcSEcCtD
Zileuton—Headache—Vinorelbine—lung cancer	0.000304	0.00167	CcSEcCtD
Zileuton—Conjunctivitis—Methotrexate—lung cancer	0.000304	0.00167	CcSEcCtD
Zileuton—Feeling abnormal—Cisplatin—lung cancer	0.0003	0.00164	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000297	0.00163	CcSEcCtD
Zileuton—Somnolence—Etoposide—lung cancer	0.000296	0.00162	CcSEcCtD
Zileuton—Insomnia—Paclitaxel—lung cancer	0.000295	0.00162	CcSEcCtD
Zileuton—Hypersensitivity—Irinotecan—lung cancer	0.000295	0.00162	CcSEcCtD
Zileuton—Somnolence—Paclitaxel—lung cancer	0.00029	0.00159	CcSEcCtD
Zileuton—Myalgia—Docetaxel—lung cancer	0.000289	0.00158	CcSEcCtD
Zileuton—Arthralgia—Docetaxel—lung cancer	0.000289	0.00158	CcSEcCtD
Zileuton—Chest pain—Docetaxel—lung cancer	0.000289	0.00158	CcSEcCtD
Zileuton—Nausea—Vinorelbine—lung cancer	0.000288	0.00158	CcSEcCtD
Zileuton—Gastrointestinal disorder—Etoposide—lung cancer	0.000287	0.00158	CcSEcCtD
Zileuton—Dyspepsia—Paclitaxel—lung cancer	0.000287	0.00158	CcSEcCtD
Zileuton—Body temperature increased—Cisplatin—lung cancer	0.000287	0.00157	CcSEcCtD
Zileuton—Pain—Etoposide—lung cancer	0.000285	0.00156	CcSEcCtD
Zileuton—Constipation—Etoposide—lung cancer	0.000285	0.00156	CcSEcCtD
Zileuton—Upper respiratory tract infection—Doxorubicin—lung cancer	0.000282	0.00155	CcSEcCtD
Zileuton—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000282	0.00154	CcSEcCtD
Zileuton—Hepatitis—Methotrexate—lung cancer	0.000281	0.00154	CcSEcCtD
Zileuton—Pain—Paclitaxel—lung cancer	0.000279	0.00153	CcSEcCtD
Zileuton—Constipation—Paclitaxel—lung cancer	0.000279	0.00153	CcSEcCtD
Zileuton—Pruritus—Gemcitabine—lung cancer	0.000276	0.00151	CcSEcCtD
Zileuton—Tiaprofenic acid—PTGS2—lung cancer	0.000275	1	CrCbGaD
Zileuton—Feeling abnormal—Etoposide—lung cancer	0.000274	0.0015	CcSEcCtD
Zileuton—Diarrhoea—Irinotecan—lung cancer	0.000274	0.0015	CcSEcCtD
Zileuton—Feeling abnormal—Paclitaxel—lung cancer	0.000269	0.00147	CcSEcCtD
Zileuton—Hypersensitivity—Cisplatin—lung cancer	0.000268	0.00147	CcSEcCtD
Zileuton—Diarrhoea—Gemcitabine—lung cancer	0.000267	0.00146	CcSEcCtD
Zileuton—Dizziness—Irinotecan—lung cancer	0.000265	0.00145	CcSEcCtD
Zileuton—Urticaria—Etoposide—lung cancer	0.000265	0.00145	CcSEcCtD
Zileuton—Jaundice—Doxorubicin—lung cancer	0.000264	0.00145	CcSEcCtD
Zileuton—Body temperature increased—Etoposide—lung cancer	0.000263	0.00144	CcSEcCtD
Zileuton—Conjunctivitis—Doxorubicin—lung cancer	0.000263	0.00144	CcSEcCtD
Zileuton—Urinary tract infection—Doxorubicin—lung cancer	0.000263	0.00144	CcSEcCtD
Zileuton—Urticaria—Paclitaxel—lung cancer	0.000259	0.00142	CcSEcCtD
Zileuton—Body temperature increased—Paclitaxel—lung cancer	0.000258	0.00141	CcSEcCtD
Zileuton—Vomiting—Irinotecan—lung cancer	0.000255	0.00139	CcSEcCtD
Zileuton—Sinusitis—Doxorubicin—lung cancer	0.000254	0.00139	CcSEcCtD
Zileuton—Rash—Irinotecan—lung cancer	0.000252	0.00138	CcSEcCtD
Zileuton—Dermatitis—Irinotecan—lung cancer	0.000252	0.00138	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000252	0.00138	CcSEcCtD
Zileuton—Headache—Irinotecan—lung cancer	0.000251	0.00137	CcSEcCtD
Zileuton—Insomnia—Docetaxel—lung cancer	0.00025	0.00137	CcSEcCtD
Zileuton—Diarrhoea—Cisplatin—lung cancer	0.000249	0.00136	CcSEcCtD
Zileuton—Vomiting—Gemcitabine—lung cancer	0.000248	0.00136	CcSEcCtD
Zileuton—Somnolence—Docetaxel—lung cancer	0.000246	0.00135	CcSEcCtD
Zileuton—Rash—Gemcitabine—lung cancer	0.000246	0.00135	CcSEcCtD
Zileuton—Dermatitis—Gemcitabine—lung cancer	0.000246	0.00135	CcSEcCtD
Zileuton—Hypersensitivity—Etoposide—lung cancer	0.000245	0.00134	CcSEcCtD
Zileuton—Headache—Gemcitabine—lung cancer	0.000244	0.00134	CcSEcCtD
Zileuton—Dyspepsia—Docetaxel—lung cancer	0.000244	0.00133	CcSEcCtD
Zileuton—Hepatitis—Doxorubicin—lung cancer	0.000243	0.00133	CcSEcCtD
Zileuton—Hypersensitivity—Paclitaxel—lung cancer	0.000241	0.00132	CcSEcCtD
Zileuton—Gastrointestinal disorder—Docetaxel—lung cancer	0.000239	0.00131	CcSEcCtD
Zileuton—Nausea—Irinotecan—lung cancer	0.000238	0.0013	CcSEcCtD
Zileuton—Constipation—Docetaxel—lung cancer	0.000237	0.0013	CcSEcCtD
Zileuton—Pain—Docetaxel—lung cancer	0.000237	0.0013	CcSEcCtD
Zileuton—Pruritus—Etoposide—lung cancer	0.000236	0.00129	CcSEcCtD
Zileuton—Nausea—Gemcitabine—lung cancer	0.000232	0.00127	CcSEcCtD
Zileuton—Vomiting—Cisplatin—lung cancer	0.000231	0.00127	CcSEcCtD
Zileuton—Pruritus—Paclitaxel—lung cancer	0.000231	0.00127	CcSEcCtD
Zileuton—Rash—Cisplatin—lung cancer	0.000229	0.00126	CcSEcCtD
Zileuton—Dermatitis—Cisplatin—lung cancer	0.000229	0.00125	CcSEcCtD
Zileuton—Feeling abnormal—Docetaxel—lung cancer	0.000228	0.00125	CcSEcCtD
Zileuton—Diarrhoea—Etoposide—lung cancer	0.000228	0.00125	CcSEcCtD
Zileuton—Ill-defined disorder—Methotrexate—lung cancer	0.000227	0.00124	CcSEcCtD
Zileuton—Diarrhoea—Paclitaxel—lung cancer	0.000223	0.00122	CcSEcCtD
Zileuton—Malaise—Methotrexate—lung cancer	0.00022	0.00121	CcSEcCtD
Zileuton—Dizziness—Etoposide—lung cancer	0.00022	0.00121	CcSEcCtD
Zileuton—Body temperature increased—Docetaxel—lung cancer	0.000219	0.0012	CcSEcCtD
Zileuton—Dizziness—Paclitaxel—lung cancer	0.000216	0.00118	CcSEcCtD
Zileuton—Nausea—Cisplatin—lung cancer	0.000216	0.00118	CcSEcCtD
Zileuton—Vomiting—Etoposide—lung cancer	0.000212	0.00116	CcSEcCtD
Zileuton—Rash—Etoposide—lung cancer	0.00021	0.00115	CcSEcCtD
Zileuton—Dermatitis—Etoposide—lung cancer	0.00021	0.00115	CcSEcCtD
Zileuton—Headache—Etoposide—lung cancer	0.000209	0.00114	CcSEcCtD
Zileuton—Flatulence—Doxorubicin—lung cancer	0.000209	0.00114	CcSEcCtD
Zileuton—Chest pain—Methotrexate—lung cancer	0.000208	0.00114	CcSEcCtD
Zileuton—Myalgia—Methotrexate—lung cancer	0.000208	0.00114	CcSEcCtD
Zileuton—Arthralgia—Methotrexate—lung cancer	0.000208	0.00114	CcSEcCtD
Zileuton—Tension—Doxorubicin—lung cancer	0.000208	0.00114	CcSEcCtD
Zileuton—Vomiting—Paclitaxel—lung cancer	0.000208	0.00114	CcSEcCtD
Zileuton—Rash—Paclitaxel—lung cancer	0.000206	0.00113	CcSEcCtD
Zileuton—Dermatitis—Paclitaxel—lung cancer	0.000206	0.00113	CcSEcCtD
Zileuton—Discomfort—Methotrexate—lung cancer	0.000206	0.00113	CcSEcCtD
Zileuton—Nervousness—Doxorubicin—lung cancer	0.000206	0.00113	CcSEcCtD
Zileuton—Headache—Paclitaxel—lung cancer	0.000205	0.00112	CcSEcCtD
Zileuton—Hypersensitivity—Docetaxel—lung cancer	0.000204	0.00112	CcSEcCtD
Zileuton—Nausea—Etoposide—lung cancer	0.000198	0.00108	CcSEcCtD
Zileuton—Ill-defined disorder—Doxorubicin—lung cancer	0.000196	0.00108	CcSEcCtD
Zileuton—Pruritus—Docetaxel—lung cancer	0.000196	0.00107	CcSEcCtD
Zileuton—Nausea—Paclitaxel—lung cancer	0.000194	0.00106	CcSEcCtD
Zileuton—Malaise—Doxorubicin—lung cancer	0.000191	0.00105	CcSEcCtD
Zileuton—Diarrhoea—Docetaxel—lung cancer	0.000189	0.00104	CcSEcCtD
Zileuton—Dizziness—Docetaxel—lung cancer	0.000183	0.001	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000182	0.000996	CcSEcCtD
Zileuton—Insomnia—Methotrexate—lung cancer	0.00018	0.000989	CcSEcCtD
Zileuton—Chest pain—Doxorubicin—lung cancer	0.00018	0.000987	CcSEcCtD
Zileuton—Arthralgia—Doxorubicin—lung cancer	0.00018	0.000987	CcSEcCtD
Zileuton—Myalgia—Doxorubicin—lung cancer	0.00018	0.000987	CcSEcCtD
Zileuton—Discomfort—Doxorubicin—lung cancer	0.000178	0.000976	CcSEcCtD
Zileuton—Somnolence—Methotrexate—lung cancer	0.000177	0.000972	CcSEcCtD
Zileuton—Vomiting—Docetaxel—lung cancer	0.000176	0.000964	CcSEcCtD
Zileuton—Dyspepsia—Methotrexate—lung cancer	0.000176	0.000962	CcSEcCtD
Zileuton—Rash—Docetaxel—lung cancer	0.000174	0.000956	CcSEcCtD
Zileuton—Dermatitis—Docetaxel—lung cancer	0.000174	0.000955	CcSEcCtD
Zileuton—Headache—Docetaxel—lung cancer	0.000173	0.00095	CcSEcCtD
Zileuton—Gastrointestinal disorder—Methotrexate—lung cancer	0.000172	0.000944	CcSEcCtD
Zileuton—Pain—Methotrexate—lung cancer	0.000171	0.000935	CcSEcCtD
Zileuton—Nausea—Docetaxel—lung cancer	0.000164	0.000901	CcSEcCtD
Zileuton—Feeling abnormal—Methotrexate—lung cancer	0.000164	0.000901	CcSEcCtD
Zileuton—Urticaria—Methotrexate—lung cancer	0.000158	0.000868	CcSEcCtD
Zileuton—Body temperature increased—Methotrexate—lung cancer	0.000158	0.000864	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000157	0.000862	CcSEcCtD
Zileuton—Insomnia—Doxorubicin—lung cancer	0.000156	0.000856	CcSEcCtD
Zileuton—Somnolence—Doxorubicin—lung cancer	0.000154	0.000841	CcSEcCtD
Zileuton—Dyspepsia—Doxorubicin—lung cancer	0.000152	0.000833	CcSEcCtD
Zileuton—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000149	0.000817	CcSEcCtD
Zileuton—Pain—Doxorubicin—lung cancer	0.000148	0.000809	CcSEcCtD
Zileuton—Constipation—Doxorubicin—lung cancer	0.000148	0.000809	CcSEcCtD
Zileuton—Hypersensitivity—Methotrexate—lung cancer	0.000147	0.000805	CcSEcCtD
Zileuton—Feeling abnormal—Doxorubicin—lung cancer	0.000142	0.00078	CcSEcCtD
Zileuton—Pruritus—Methotrexate—lung cancer	0.000141	0.000773	CcSEcCtD
Zileuton—Urticaria—Doxorubicin—lung cancer	0.000137	0.000752	CcSEcCtD
Zileuton—Body temperature increased—Doxorubicin—lung cancer	0.000137	0.000748	CcSEcCtD
Zileuton—Diarrhoea—Methotrexate—lung cancer	0.000136	0.000748	CcSEcCtD
Zileuton—Dizziness—Methotrexate—lung cancer	0.000132	0.000723	CcSEcCtD
Zileuton—Hypersensitivity—Doxorubicin—lung cancer	0.000127	0.000697	CcSEcCtD
Zileuton—Vomiting—Methotrexate—lung cancer	0.000127	0.000695	CcSEcCtD
Zileuton—Rash—Methotrexate—lung cancer	0.000126	0.000689	CcSEcCtD
Zileuton—Dermatitis—Methotrexate—lung cancer	0.000126	0.000689	CcSEcCtD
Zileuton—Headache—Methotrexate—lung cancer	0.000125	0.000685	CcSEcCtD
Zileuton—Pruritus—Doxorubicin—lung cancer	0.000122	0.00067	CcSEcCtD
Zileuton—Nausea—Methotrexate—lung cancer	0.000118	0.000649	CcSEcCtD
Zileuton—Diarrhoea—Doxorubicin—lung cancer	0.000118	0.000648	CcSEcCtD
Zileuton—Dizziness—Doxorubicin—lung cancer	0.000114	0.000626	CcSEcCtD
Zileuton—Vomiting—Doxorubicin—lung cancer	0.00011	0.000602	CcSEcCtD
Zileuton—Rash—Doxorubicin—lung cancer	0.000109	0.000597	CcSEcCtD
Zileuton—Dermatitis—Doxorubicin—lung cancer	0.000109	0.000596	CcSEcCtD
Zileuton—Headache—Doxorubicin—lung cancer	0.000108	0.000593	CcSEcCtD
Zileuton—Nausea—Doxorubicin—lung cancer	0.000103	0.000562	CcSEcCtD
Zileuton—LTB4R—Signaling Pathways—STAT3—lung cancer	2.54e-05	0.000132	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—NRAS—lung cancer	2.54e-05	0.000132	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—HSD17B10—lung cancer	2.53e-05	0.000132	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—MTMR3—lung cancer	2.52e-05	0.000131	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—PIK3CD—lung cancer	2.51e-05	0.000131	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—ALB—lung cancer	2.48e-05	0.000129	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PGAM1—lung cancer	2.45e-05	0.000128	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—ENO1—lung cancer	2.45e-05	0.000128	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	2.44e-05	0.000127	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—MAPK3—lung cancer	2.43e-05	0.000126	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—ALB—lung cancer	2.41e-05	0.000126	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—STK11—lung cancer	2.41e-05	0.000125	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—PIK3CA—lung cancer	2.4e-05	0.000125	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ATP5H—lung cancer	2.4e-05	0.000125	CbGpPWpGaD
Zileuton—CYP3A4—Biological oxidations—POMC—lung cancer	2.39e-05	0.000124	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—MYC—lung cancer	2.36e-05	0.000123	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—CKB—lung cancer	2.35e-05	0.000123	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—CYP2A7—lung cancer	2.34e-05	0.000122	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—EGFR—lung cancer	2.31e-05	0.00012	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—SDC4—lung cancer	2.29e-05	0.000119	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.26e-05	0.000118	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—GSTP1—lung cancer	2.23e-05	0.000116	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—CNDP2—lung cancer	2.21e-05	0.000115	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—GSTM2—lung cancer	2.21e-05	0.000115	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—CYP2E1—lung cancer	2.2e-05	0.000115	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—PIK3CB—lung cancer	2.19e-05	0.000114	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—KRAS—lung cancer	2.18e-05	0.000114	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—NQO1—lung cancer	2.18e-05	0.000113	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—PTGS2—lung cancer	2.17e-05	0.000113	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—CAT—lung cancer	2.17e-05	0.000113	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.15e-05	0.000112	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—MTMR3—lung cancer	2.15e-05	0.000112	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PLBD1—lung cancer	2.14e-05	0.000111	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.13e-05	0.000111	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	2.11e-05	0.00011	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—ABCB1—lung cancer	2.11e-05	0.00011	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PGAM1—lung cancer	2.1e-05	0.000109	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—GSTA3—lung cancer	2.09e-05	0.000109	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—RRM1—lung cancer	2.09e-05	0.000109	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—TYMS—lung cancer	2.07e-05	0.000108	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—GSTM1—lung cancer	2.05e-05	0.000106	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—PIK3CA—lung cancer	2e-05	0.000104	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—CYP2A7—lung cancer	2e-05	0.000104	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—B4GALT5—lung cancer	1.96e-05	0.000102	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—STK11—lung cancer	1.96e-05	0.000102	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—AKT1—lung cancer	1.96e-05	0.000102	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—SDC4—lung cancer	1.96e-05	0.000102	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—HSD17B10—lung cancer	1.95e-05	0.000102	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—TP53—lung cancer	1.94e-05	0.000101	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—CYP1A1—lung cancer	1.94e-05	0.000101	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—ERCC2—lung cancer	1.92e-05	0.0001	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—GSTA4—lung cancer	1.91e-05	9.94e-05	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—PTEN—lung cancer	1.89e-05	9.84e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	1.87e-05	9.71e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—GSTA2—lung cancer	1.86e-05	9.69e-05	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—HRAS—lung cancer	1.85e-05	9.66e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.84e-05	9.58e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—CKB—lung cancer	1.82e-05	9.46e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—GSTP1—lung cancer	1.81e-05	9.45e-05	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—EP300—lung cancer	1.8e-05	9.39e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—GSTA1—lung cancer	1.79e-05	9.34e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—RRM1—lung cancer	1.78e-05	9.29e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—GSTA3—lung cancer	1.78e-05	9.29e-05	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—IL6—lung cancer	1.78e-05	9.24e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—ABCC3—lung cancer	1.77e-05	9.24e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—CAT—lung cancer	1.77e-05	9.19e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.76e-05	9.14e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—AKR1C1—lung cancer	1.72e-05	8.95e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—ABCB1—lung cancer	1.72e-05	8.94e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—CNDP2—lung cancer	1.71e-05	8.89e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—GSTM2—lung cancer	1.71e-05	8.89e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—TYMS—lung cancer	1.69e-05	8.78e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—B4GALT5—lung cancer	1.68e-05	8.73e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—UGT1A1—lung cancer	1.67e-05	8.69e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—GSTM1—lung cancer	1.67e-05	8.68e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—APOA1—lung cancer	1.66e-05	8.66e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—MTMR3—lung cancer	1.66e-05	8.65e-05	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—AKT1—lung cancer	1.64e-05	8.53e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—GSTA4—lung cancer	1.63e-05	8.49e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PGAM1—lung cancer	1.62e-05	8.43e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—GNG11—lung cancer	1.61e-05	8.38e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.6e-05	8.33e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	1.59e-05	8.3e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.59e-05	8.29e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—GSTA2—lung cancer	1.59e-05	8.28e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—CYP1A1—lung cancer	1.58e-05	8.23e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—ERCC2—lung cancer	1.57e-05	8.16e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—CYP2A7—lung cancer	1.54e-05	8.04e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—GSTA1—lung cancer	1.53e-05	7.99e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—ALDOA—lung cancer	1.53e-05	7.98e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PIK3CG—lung cancer	1.52e-05	7.91e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—ABCC3—lung cancer	1.52e-05	7.9e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—SDC4—lung cancer	1.51e-05	7.87e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—NCOA3—lung cancer	1.49e-05	7.74e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—AKR1C1—lung cancer	1.47e-05	7.65e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.46e-05	7.61e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—ADCY1—lung cancer	1.45e-05	7.53e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—ABCG2—lung cancer	1.45e-05	7.53e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—POMC—lung cancer	1.45e-05	7.53e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—UGT1A1—lung cancer	1.43e-05	7.42e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—HPGDS—lung cancer	1.42e-05	7.39e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—ENO2—lung cancer	1.42e-05	7.39e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PPP2R1B—lung cancer	1.41e-05	7.34e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—CREBBP—lung cancer	1.41e-05	7.33e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.39e-05	7.24e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—GSTA3—lung cancer	1.38e-05	7.17e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—RRM1—lung cancer	1.38e-05	7.17e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—GSTT1—lung cancer	1.38e-05	7.16e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—GNG11—lung cancer	1.37e-05	7.16e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.37e-05	7.12e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—GCLC—lung cancer	1.36e-05	7.08e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—CYP2A6—lung cancer	1.36e-05	7.08e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—APOA1—lung cancer	1.36e-05	7.06e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.35e-05	7.05e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PIK3CD—lung cancer	1.34e-05	6.95e-05	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—PIK3CA—lung cancer	1.33e-05	6.94e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—ALB—lung cancer	1.32e-05	6.86e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—ALDOA—lung cancer	1.31e-05	6.82e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.3e-05	6.76e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—B4GALT5—lung cancer	1.29e-05	6.74e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—ENO1—lung cancer	1.29e-05	6.71e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.28e-05	6.69e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—NCOA3—lung cancer	1.27e-05	6.62e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.27e-05	6.6e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—GSTA4—lung cancer	1.26e-05	6.55e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.25e-05	6.5e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PIK3CG—lung cancer	1.24e-05	6.45e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—ABCG2—lung cancer	1.24e-05	6.44e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—ADCY1—lung cancer	1.24e-05	6.44e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—GSTA2—lung cancer	1.23e-05	6.39e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—ENO2—lung cancer	1.21e-05	6.31e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—HPGDS—lung cancer	1.21e-05	6.31e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PPP2R1B—lung cancer	1.2e-05	6.27e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.19e-05	6.19e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—GSTA1—lung cancer	1.18e-05	6.16e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—POMC—lung cancer	1.18e-05	6.14e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—GSTT1—lung cancer	1.18e-05	6.12e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ABCC3—lung cancer	1.17e-05	6.09e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PIK3CB—lung cancer	1.16e-05	6.06e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—GCLC—lung cancer	1.16e-05	6.05e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—CYP2A6—lung cancer	1.16e-05	6.05e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.16e-05	6.03e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—CYP2E1—lung cancer	1.16e-05	6.02e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PTGS2—lung cancer	1.15e-05	6e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—CREBBP—lung cancer	1.15e-05	5.98e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—NQO1—lung cancer	1.14e-05	5.95e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—AKR1C1—lung cancer	1.13e-05	5.9e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.12e-05	5.83e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.11e-05	5.78e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—ENO1—lung cancer	1.1e-05	5.74e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—UGT1A1—lung cancer	1.1e-05	5.73e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.1e-05	5.72e-05	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—AKT1—lung cancer	1.09e-05	5.67e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PIK3CD—lung cancer	1.09e-05	5.67e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.08e-05	5.64e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—ALB—lung cancer	1.07e-05	5.59e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—GNG11—lung cancer	1.06e-05	5.52e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—STK11—lung cancer	1.03e-05	5.37e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ALDOA—lung cancer	1.01e-05	5.26e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PTEN—lung cancer	1.01e-05	5.24e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—CYP2E1—lung cancer	9.88e-06	5.15e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—NCOA3—lung cancer	9.81e-06	5.11e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—NQO1—lung cancer	9.77e-06	5.09e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	9.68e-06	5.04e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—EP300—lung cancer	9.59e-06	4.99e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	9.57e-06	4.98e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ABCG2—lung cancer	9.54e-06	4.97e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ADCY1—lung cancer	9.54e-06	4.97e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—GSTP1—lung cancer	9.54e-06	4.97e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PIK3CB—lung cancer	9.49e-06	4.94e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	9.48e-06	4.94e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PTGS2—lung cancer	9.4e-06	4.89e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—HPGDS—lung cancer	9.36e-06	4.87e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ENO2—lung cancer	9.36e-06	4.87e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PPP2R1B—lung cancer	9.3e-06	4.84e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—CAT—lung cancer	9.28e-06	4.83e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	9.23e-06	4.8e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—GSTT1—lung cancer	9.08e-06	4.73e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—ABCB1—lung cancer	9.03e-06	4.7e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—CYP2A6—lung cancer	8.97e-06	4.67e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—GCLC—lung cancer	8.97e-06	4.67e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—TYMS—lung cancer	8.87e-06	4.62e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—STK11—lung cancer	8.81e-06	4.59e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—GSTM1—lung cancer	8.76e-06	4.56e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ENO1—lung cancer	8.5e-06	4.43e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—CYP1A1—lung cancer	8.31e-06	4.33e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	8.27e-06	4.31e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—ERCC2—lung cancer	8.24e-06	4.29e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PTEN—lung cancer	8.2e-06	4.27e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—GSTP1—lung cancer	8.15e-06	4.24e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—CAT—lung cancer	7.93e-06	4.13e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	7.89e-06	4.11e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—EP300—lung cancer	7.82e-06	4.07e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—ABCB1—lung cancer	7.72e-06	4.02e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—CYP2E1—lung cancer	7.63e-06	3.97e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—TYMS—lung cancer	7.58e-06	3.95e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—NQO1—lung cancer	7.54e-06	3.93e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—GSTM1—lung cancer	7.49e-06	3.9e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—APOA1—lung cancer	7.13e-06	3.71e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—CYP1A1—lung cancer	7.1e-06	3.7e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PIK3CA—lung cancer	7.09e-06	3.69e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—ERCC2—lung cancer	7.04e-06	3.67e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	6.83e-06	3.55e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—STK11—lung cancer	6.8e-06	3.54e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PIK3CG—lung cancer	6.51e-06	3.39e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—GSTP1—lung cancer	6.29e-06	3.28e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—POMC—lung cancer	6.2e-06	3.23e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—CAT—lung cancer	6.12e-06	3.19e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—APOA1—lung cancer	6.09e-06	3.17e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—CREBBP—lung cancer	6.03e-06	3.14e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ABCB1—lung cancer	5.95e-06	3.1e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—TYMS—lung cancer	5.85e-06	3.04e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	5.83e-06	3.04e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—AKT1—lung cancer	5.8e-06	3.02e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PIK3CA—lung cancer	5.78e-06	3.01e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—GSTM1—lung cancer	5.78e-06	3.01e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PIK3CD—lung cancer	5.72e-06	2.98e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—ALB—lung cancer	5.65e-06	2.94e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PIK3CG—lung cancer	5.56e-06	2.9e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—CYP1A1—lung cancer	5.48e-06	2.85e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ERCC2—lung cancer	5.43e-06	2.83e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—POMC—lung cancer	5.29e-06	2.76e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—CREBBP—lung cancer	5.16e-06	2.68e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PIK3CB—lung cancer	4.99e-06	2.6e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PTGS2—lung cancer	4.94e-06	2.57e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PIK3CD—lung cancer	4.89e-06	2.55e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—ALB—lung cancer	4.83e-06	2.51e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—AKT1—lung cancer	4.72e-06	2.46e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—APOA1—lung cancer	4.7e-06	2.45e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PTEN—lung cancer	4.31e-06	2.24e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PIK3CG—lung cancer	4.29e-06	2.23e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PIK3CB—lung cancer	4.26e-06	2.22e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PTGS2—lung cancer	4.22e-06	2.2e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—EP300—lung cancer	4.11e-06	2.14e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—POMC—lung cancer	4.09e-06	2.13e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—CREBBP—lung cancer	3.98e-06	2.07e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PIK3CD—lung cancer	3.77e-06	1.96e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ALB—lung cancer	3.72e-06	1.94e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PTEN—lung cancer	3.68e-06	1.92e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—EP300—lung cancer	3.51e-06	1.83e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PIK3CB—lung cancer	3.29e-06	1.71e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PTGS2—lung cancer	3.26e-06	1.7e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PIK3CA—lung cancer	3.04e-06	1.58e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PTEN—lung cancer	2.84e-06	1.48e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—EP300—lung cancer	2.71e-06	1.41e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PIK3CA—lung cancer	2.6e-06	1.35e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—AKT1—lung cancer	2.48e-06	1.29e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—AKT1—lung cancer	2.12e-06	1.1e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PIK3CA—lung cancer	2e-06	1.04e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—AKT1—lung cancer	1.64e-06	8.53e-06	CbGpPWpGaD
